Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Elikia Inc.
Entity

Elikia Inc.

Tracked across 1 events · 6 articles · First seen Aug 20, 2026 · Last active Aug 21, 2026

Sentiment
15
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 15
Tech
Prostate cancer amino acid metabolism resistance study
Weill Cornell Medicine investigators published a preclinical study in Nature Metabolism on August 20, 2026, revealing that prostate cancer cells can rewire amino acid metabolism to override normal cholesterol production controls, potentially fueling hormone therapy…
Impact: Founded by the study's authors; the research may increase interest in its aging-related metabolic dysfunction programs.
Aug 20, 2026 · 6 articles
Key Actions (2)
20 John Blenis founded company Elikia Inc.Prostate cancer amino acid...
20 Zhongchi Li founded company Elikia Inc.Prostate cancer amino acid...
ERGEN INTELLIGENCE
Track Elikia Inc. live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.